- Report
- February 2024
- 125 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- February 2024
- 137 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- December 2023
- 111 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- December 2023
- 180 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- November 2023
- 175 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- October 2024
- 199 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- June 2024
- 163 Pages
Global
From €2242EUR$2,350USD£1,878GBP
- Report
- May 2024
- 250 Pages
Global
From €2862EUR$3,000USD£2,398GBP
- Report
- October 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- September 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- September 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- September 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more